当前位置: 首页 > 期刊 > 《中国医学创新》 > 20204
编号:13508474
TNF-α、IL-1β及IL-6水平用于评估川崎病患儿发生冠状动脉损伤的临床价值(4)
http://www.100md.com 2020年2月5日 《中国医学创新》 20204
     [11]龚本新,卢宏柱.川崎病患儿血清促炎因子检测的临床意义[J].医学信息,2010,23(12):4481-4482.

    [12]宋瑞霞,李晓惠,张霆,等.血小板反应蛋白2对川崎病患儿冠状动脉扩张的预测价值[J].中华儿科杂志,2016,54(4):259-263.

    [13] Yin W,Wang X,Ding Y,et al.Expression of nuclear factor-κBp65 in mononuclear cells in Kawasaki disease and its relation tocoronary artery lesions[J].Indian J Pediatr,2011,78(11):1378-1382.

    [14] McGrath K C,Li X H,McRobb L S,et al.Inhibitory Effect of a French Maritime Pine Bark Extract-Based Nutritional Supplement on TNF-α-Induced Inflammation and Oxidative Stress in Human Coronary Artery Endothelial Cells[J].Evid Based Complement Alternat Med,2015(3):1-7.

    [15] Wu L,Ramirez S H,Andrews A M,et al.Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability[J].J Neurochem,2016,136(2):250-257.

    [16] Yin Y W,Li J C,Zhang M,et al.Erratum to “Influence of interleukin-6 gene-174G>C polymorphism on development of atherosclerosis: A meta-analysis of 50 studies involving 33,514 subjects” [Gene 529 (2013) 94-103][J].Gene,2014,534(2):456.

    (收稿日期:2019-07-11) (本文編辑:姬思雨), 百拇医药(黄宏琳 黄育坤 林淑斌 郭瑞芳)
上一页1 2 3 4